Jennifer E Schuster, Natasha B Halasa, Mari Nakamura, Emily R Levy, Julie C Fitzgerald, Cameron C Young, Margaret M Newhams, Florence Bourgeois, Mary A Staat, Charlotte V Hobbs, Heda Dapul, Leora R Feldstein, Ashley M Jackson, Elizabeth H Mack, Tracie C Walker, Aline B Maddux, Philip C Spinella, Laura L Loftis, Michele Kong, Courtney M Rowan, Melania M Bembea, Gwenn E McLaughlin, Mark W Hall, Christopher J Babbitt, Mia Maamari, Matt S Zinter, Natalie Z Cvijanovich, Kelly N Michelson, Shira J Gertz, Christopher L Carroll, Neal J Thomas, John S Giuliano, Aalok R Singh, Saul R Hymes, Adam J Schwarz, John K McGuire, Ryan A Nofziger, Heidi R Flori, Katharine N Clouser, Kari Wellnitz, Melissa L Cullimore, Janet R Hume, Manish Patel, Adrienne G Randolph
BACKGROUND: It is unclear how acute coronavirus disease 2019 (COVID-19)-directed therapies are used in children with life-threatening COVID-19 in US hospitals. We described characteristics of children hospitalized in the intensive care unit or step-down unit (ICU/SDU) who received COVID-19-directed therapies and the specific therapies administered. METHODS: Between March 15, 2020 and December 27, 2020, children <18 years of age in the ICU/SDU with acute COVID-19 at 48 pediatric hospitals in the United States were identified...
May 30, 2022: Journal of the Pediatric Infectious Diseases Society